Related Experiment Video
Updated: Oct 31, 2025
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
7.1K
Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
Benjamin Wadowski1, Raphael Bueno1, Assunta De Rienzo1
1Thoracic Surgery Oncology Laboratory and the International Mesothelioma Program, Division of Thoracic and Cardiovascular Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Frontiers in Oncology
|June 28, 2021
Summary
Malignant pleural mesothelioma (MPM) is a rare cancer with limited treatments. Understanding MPM genetics, epigenetics, and transcriptomics is key to improving immune response and predicting immunotherapy success.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer with poor therapeutic options.
- Immune checkpoint inhibitors show promise but have varied efficacy in MPM patients.
- Predicting response to immunotherapy in MPM remains a challenge.
Purpose of the Study:
- To review the interplay between MPM genetics and the immune microenvironment.
- To explore how genetic, epigenetic, and transcriptomic features influence immune response in MPM.
- To understand the molecular basis for varied responses to immune checkpoint inhibition in MPM.
Main Methods:
- Review of current evidence on MPM genetics, epigenetics, and transcriptomics.
- Analysis of the relationship between molecular features and immune response.
- Examination of next-generation sequencing (NGS) data in MPM.
Main Results:
- Limited response to immune checkpoint inhibitors in a subset of MPM patients.
- Next-generation sequencing advances understanding of MPM molecular features.
- Correlation between immune-related gene expression and treatment success in other cancers.
Conclusions:
- MPM genetics significantly impacts the immune microenvironment.
- Further research into MPM's molecular landscape is crucial for developing effective immunotherapies.
- Understanding genetic signatures may improve prediction of immunotherapy response in MPM.
Related Concept Videos
02:17The Tumor Microenvironment
7.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
01:30Pleural Disorders: Types and Brief Description
398
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
398
02:23Abnormal Proliferation
4.8K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
02:59Cancer Prevention
7.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.1K
01:06Induced Pluripotent Stem Cells
4.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.7K